ProHance 279.3 mg/mL
gadoteridol · INJECTION, SOLUTION · Bracco Diagnostics Inc
No Recall History
Plain English
ProHance is a injection, solution containing gadoteridol at 279.3 mg/mL, taken intravenous. Manufactured by Bracco Diagnostics Inc.
Key Facts
- Brand Name
- ProHance
- Generic Name
- gadoteridol
- NDC Code (Product)
0270-1111- Manufacturer
- Bracco Diagnostics Inc
- Strength
- 279.3 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA021489
- Drug Class
- Paramagnetic Contrast Agent [EPC]
- Marketing Start
- 10/09/2003
Recall History
No Recall HistoryFrequently Asked Questions
What is ProHance used for?
ProHance contains gadoteridol. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is ProHance a controlled substance?
ProHance is not classified as a controlled substance by the DEA.
What is the generic name for ProHance?
The generic name for ProHance is gadoteridol. There are 1 other brand versions of gadoteridol.
What is the NDC code for ProHance 279.3 mg/mL?
The NDC (National Drug Code) for ProHance 279.3 mg/mL is 0270-1111, listed by Bracco Diagnostics Inc.